2OHOA |
2-hydroxyoleic acid |
ATRT |
atypical teratoid/rhabdoid tumor |
ATRX |
α thalassemia/intellectual disability syndrome X–linked gene |
BBB |
blood–brain barrier |
BRAF |
B-Raf proto-oncogene serine/threonineprotein kinase |
CAR |
chimeric antigen receptor |
CNS |
central nervous system |
CSF |
cerebrospinal fluid |
DIPG |
diffuse intrinsic pontine glioma |
DNETs |
dysembryoplastic neuroepithelial tumors |
ETMR |
embryonal tumor with multilayer rosettes |
FABP |
fatty-acid-binding protein |
GBMs |
glioblastomas |
HGG |
high-grade glioma |
LGG |
low-grade glioma |
MAPK |
mitogen-activated protein kinase |
MRSI |
proton magnetic resonance spectroscopic imaging |
MS |
mass spectroscopy |
NMR |
nuclear magnetic resonance |
OS |
overall survival |
PA |
pilocytic astrocytoma |
PBTs |
pediatric brain tumors |
PFS |
progression-free survival |
pLGG/HGG |
pediatric low-/high-grade glioma |
PXA |
pleomorphic xanthoastrocytoma |
SCD |
stearoyl CoA desaturase |
SEGA |
subependymal giant cell astrocytomas |
SHH |
Sonic Hedgehog |
SMO |
smoothened: frizzled class receptor |
SM |
sphingomyelin |
SUFU |
suppressor of fused homolog (Drosophila) |
TP53 |
tumor protein p53 |
WHO |
World Health Organization |
WT |
wild-type |